Search Icon
CRVS Archived Articles

Corvus Pharmaceuticals (CRVS): A Promising Oncology Powerhouse Emerging on the Clinical Stage

Published on November 02, 2024

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) - Unlocking the Potential of ITK Inhibition Across Oncology and Autoimmune Indications

Published on September 24, 2024